Two CpGs (−1420 and −1224) were studied based on findings of Falkenberg and colleagues (2011) (link) and Paquette and colleagues (2013) (link). Saliva samples were obtained using the Oragene DISCOVER kits (OGR-575) for Assisted Collections (DNA Genotek, Kanata, Ontario, Canada), and DNA was isolated following the manufacturer’s instructions. A 276 bp. region of the HTR2A promoter region (Chr 7: 28415063-28414801) was amplified from bisulfite modified DNA using the pyromark PCR kit (Qiagen, 203443), and DNA methylation assessed through pyrosequencing following a serial pyrosequencing protocol using a PyroMark MD system (Qiagen) and two sequencing primers as described in Paquette et al (2013) (link). Each pyrosequencing assay contained a bisulfite conversion control to assess conversion efficiency. All samples examined demonstrated >95% conversion.